Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

PEGPH20 × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 14 Tumor-Agnostic 3 Thoracic 1 Breast 1

Conditions

Recurrence 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 1017 Cisplatin 795 Pemetrexed 730 pembrolizumab 543 Paclitaxel 521 Docetaxel 474 Gemcitabine 367 Radiotherapy 349 Erlotinib Hydrochloride 340 Bevacizumab 296 Nivolumab 294 Etoposide 263 durvalumab 240 Drug Therapy 220 osimertinib 204 atezolizumab 194 Radiosurgery 165 Gefitinib 162 Vinorelbine 134 Magnetic Resonance Spectroscopy 120 130-nm albumin-bound paclitaxel 109 Ipilimumab 106 Cetuximab 97 Topotecan 93 Specimen Handling 91 Cyclophosphamide 91 Surgical Procedures, Operative 90 Blood Specimen Collection 87 tislelizumab 85 anlotinib 84

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02346370 2019-02-08

PRIMAL

Halozyme Therapeutics

Phase 1 Terminated

16 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡